This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Talk:Dangerous drug combinations/Archive 1: Difference between revisions
>Oskykins |
>Oskykins |
||
| Line 67: | Line 67: | ||
==Serotonin Releasers== | ==Serotonin Releasers== | ||
The main method of action on this group of drugs is releasing serotonin in the brain | The main method of action on this group of drugs is releasing serotonin in the brain. As such they should be used in moderation when mixed with each other and should not be mixed with serotonin reuptake inhibitors. | ||
Common serotonin releasers: [[MDMA]], [[MDA]], MDEA, 6-APB, 5-APB, MDAI, Mephedrone, Methylone | Common serotonin releasers: [[MDMA]], [[MDA]], MDEA, 6-APB, 5-APB, MDAI, Mephedrone, Methylone | ||
Serotonin reuptake inhibiting hallucinogens: aMT, [[DXM]] | |||
=Possible Heart Risk= | =Possible Heart Risk= | ||